Our previous studies indicated that deletion of Gal-3 attenuates several T cell mediated autoimmune diseases such as diabetes4, experimental autoimmune encephalomyelitis3, and inflammatory diseases including liver damage induced by T and NKT cells7, 8. This evidence concerns the gene LGALS3 and autoimmune disease.